• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

墨西哥糖尿病和高血压的流行病学及经济负担面临的挑战。

Challenges on the epidemiological and economic burden of diabetes and hypertension in Mexico.

作者信息

Arredondo Armando, Orozco Emanuel, Alcalde-Rabanal Jaqueline, Navarro Juan, Azar Alejandra

机构信息

Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.

Instituto de Saúde Coletiva, Universidade Federal da Bahía, Salvador, BA, Brasil.

出版信息

Rev Saude Publica. 2018;52:23. doi: 10.11606/s1518-8787.2018052000293. Epub 2018 Feb 26.

DOI:10.11606/s1518-8787.2018052000293
PMID:29489993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5825121/
Abstract

OBJECTIVE To analyze the epidemiological and economic burden of the health services demand due to diabetes and hypertension in Mexico. METHODS Evaluation study based on a time series study that had as a universe of study the assured and uninsured population that demands health services from the three main institutions of the Health System in Mexico: The Health Department, the Mexican Institute of Social Security, and Institute of Services and Social Security for State Workers. The financing method was based on instrumentation and consensus techniques for medium case management. In order to estimate the epidemiological changes and financial requirements, a time series of observed cases for diabetes and hypertension 1994-2013 was integrated. Probabilistic models were developed based on the Box-Jenkins technique for the period of 2013-2018 with 95% confidence intervals and p < 0.05. RESULTS Comparing results from 2013 versus 2018, in the five regions, different incremental trends of 14%-17% in epidemiological changes and 58%-66% in the economic burden for both diseases were observed. CONCLUSIONS If the risk factors and the different models of care remained as they currently are in the three institutions analyzed, the financial consequences would be of greater impact for the Mexican Institute of Social Security, following in order of importance the Institute of Services and Social Security for State Workers and lastly the Health Department. The financial needs for both diseases will represent approximately 13%-15% of the total budget allocated to the uninsured population and 15%-17% for the population insured depending on the region.

摘要

目的 分析墨西哥糖尿病和高血压导致的卫生服务需求的流行病学及经济负担。方法 基于时间序列研究的评估研究,研究对象为向墨西哥卫生系统的三个主要机构(卫生部、墨西哥社会保障局和国家工作人员服务与社会保障局)寻求卫生服务的参保和未参保人群。融资方法基于中等病例管理的工具和共识技术。为了估计流行病学变化和资金需求,整合了1994 - 2013年糖尿病和高血压观察病例的时间序列。基于Box - Jenkins技术开发了2013 - 2018年期间的概率模型,置信区间为95%,p < 0.05。结果 比较2013年与2018年的结果,在五个地区,观察到两种疾病的流行病学变化有14% - 17%的不同增量趋势,经济负担有58% - 66%的不同增量趋势。结论 如果在分析的三个机构中风险因素和不同的护理模式保持不变,对墨西哥社会保障局的财务影响将更大,其次是国家工作人员服务与社会保障局,最后是卫生部,按重要性排序。这两种疾病的资金需求将分别占分配给未参保人群总预算的约13% - 15%和参保人群的15% - 17%,具体取决于地区。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd8/5825121/ee6e8d545d71/0034-8910-rsp-S1518-52-87872018052000293-gf04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd8/5825121/7bc21ba2d641/0034-8910-rsp-S1518-52-87872018052000293-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd8/5825121/a5c7e09100fa/0034-8910-rsp-S1518-52-87872018052000293-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd8/5825121/c34cc52f889f/0034-8910-rsp-S1518-52-87872018052000293-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd8/5825121/ee6e8d545d71/0034-8910-rsp-S1518-52-87872018052000293-gf04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd8/5825121/7bc21ba2d641/0034-8910-rsp-S1518-52-87872018052000293-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd8/5825121/a5c7e09100fa/0034-8910-rsp-S1518-52-87872018052000293-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd8/5825121/c34cc52f889f/0034-8910-rsp-S1518-52-87872018052000293-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd8/5825121/ee6e8d545d71/0034-8910-rsp-S1518-52-87872018052000293-gf04.jpg

相似文献

1
Challenges on the epidemiological and economic burden of diabetes and hypertension in Mexico.墨西哥糖尿病和高血压的流行病学及经济负担面临的挑战。
Rev Saude Publica. 2018;52:23. doi: 10.11606/s1518-8787.2018052000293. Epub 2018 Feb 26.
2
Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico.拉丁美洲慢性病流行变化的医疗保健成本及财务后果:来自墨西哥的证据。
Public Health. 2005 Aug;119(8):711-20. doi: 10.1016/j.puhe.2005.01.009.
3
Costs and epidemiological changes of chronic diseases: implications and challenges for health systems.慢性病的成本与流行病学变化:对卫生系统的影响与挑战
PLoS One. 2015 Mar 17;10(3):e0118611. doi: 10.1371/journal.pone.0118611. eCollection 2015.
4
[Financial requirements for health services demands for diabetes and hypertension in Mexico: 2001-2003].[墨西哥糖尿病和高血压医疗服务需求的财务要求:2001 - 2003年]
Rev Invest Clin. 2001 Sep-Oct;53(5):422-9.
5
[The cost of diabetes in Latin America: evidence from Mexico].[拉丁美洲糖尿病的成本:来自墨西哥的证据]
Value Health. 2011 Jul-Aug;14(5 Suppl 1):S85-8. doi: 10.1016/j.jval.2011.05.022.
6
Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case.中等收入国家糖尿病流行状况变化的经济后果:以墨西哥为例。
Diabetes Care. 2004 Jan;27(1):104-9. doi: 10.2337/diacare.27.1.104.
7
Epidemiologic changes and economic burden of hypertension in Latin America: evidence from Mexico.拉丁美洲高血压的流行病学变化与经济负担:来自墨西哥的证据
Am J Hypertens. 2006 Jun;19(6):553-9. doi: 10.1016/j.amjhyper.2005.10.028.
8
Health disparities from economic burden of diabetes in middle-income countries: evidence from México.中低收入国家糖尿病经济负担导致的健康差距:来自墨西哥的证据。
PLoS One. 2013 Jul 12;8(7):e68443. doi: 10.1371/journal.pone.0068443. Print 2013.
9
Epidemiological and financial indicators of hypertension in older adults in Mexico: challenges for health planning and management in Latin America.墨西哥老年人高血压的流行病学和财务指标:拉丁美洲卫生规划与管理面临的挑战
Int J Health Plann Manage. 2017 Apr;32(2):e121-e136. doi: 10.1002/hpm.2362. Epub 2016 May 30.
10
Challenges of the epidemiological and economic burdens associated with hypertension in middle income countries: evidence from Mexico.中等收入国家高血压相关的流行病学和经济负担挑战:来自墨西哥的证据。
BMC Public Health. 2015 Nov 6;15:1106. doi: 10.1186/s12889-015-2430-x.

引用本文的文献

1
Psychological Factors and Prevalence of Diabetes and Prediabetes in a United States-Mexico Border Community.美国-墨西哥边境社区的心理因素与糖尿病及糖尿病前期患病率
Ethn Dis. 2025 Mar 17;35(1):17-26. doi: 10.18865/EthnDis-2024-3. eCollection 2025 Mar.
2
Risk Factors Associated with the Development of Hospital-Acquired Infections in Hospitalized Patients with Severe COVID-19.与重症 COVID-19 住院患者发生医院获得性感染相关的危险因素
Antibiotics (Basel). 2023 Jun 27;12(7):1108. doi: 10.3390/antibiotics12071108.
3
Comparison of Diabetes Mellitus Risk Factors in Mexico in 2003 and 2014.

本文引用的文献

1
Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine.拉丁美洲的2型糖尿病与医疗保健成本:探讨加强预防医学的必要性。
BMC Med. 2014 Aug 19;12:136. doi: 10.1186/s12916-014-0136-z.
2
Characterizing the financial burden of pulmonary arterial hypertension within an integrated healthcare delivery system.在综合医疗服务体系内刻画肺动脉高压的经济负担。
J Med Econ. 2013 Dec;16(12):1414-22. doi: 10.3111/13696998.2013.849713. Epub 2013 Oct 22.
3
Contagion: epidemiological models and financial crises.
2003年与2014年墨西哥糖尿病风险因素比较
Front Nutr. 2022 Jun 30;9:894904. doi: 10.3389/fnut.2022.894904. eCollection 2022.
4
Blood Pressure Changes After a Health Promotion Program Among Mexican Workers.健康促进计划对墨西哥工人血压的影响。
Front Public Health. 2021 Jun 23;9:683655. doi: 10.3389/fpubh.2021.683655. eCollection 2021.
5
Direct cost of systemic arterial hypertension and its complications in the circulatory system from the perspective of the Brazilian public health system in 2019.2019 年巴西公共卫生系统视角下的系统性动脉高血压及其循环系统并发症的直接成本。
PLoS One. 2021 Jun 10;16(6):e0253063. doi: 10.1371/journal.pone.0253063. eCollection 2021.
6
Cardiovascular Risk Factors and Social Development Index.心血管危险因素与社会发展指数
Front Cardiovasc Med. 2021 Feb 23;8:631747. doi: 10.3389/fcvm.2021.631747. eCollection 2021.
7
Incorporating genomic medicine into primary-level health care for chronic non-communicable diseases in Mexico: A qualitative study.将基因组医学纳入墨西哥基层卫生保健以治疗慢性非传染性疾病:一项定性研究。
Int J Health Plann Manage. 2020 Nov;35(6):1426-1437. doi: 10.1002/hpm.3053. Epub 2020 Sep 1.
8
A global perspective on the costs of hypertension: a systematic review.高血压成本的全球视角:系统评价
Arch Med Sci. 2020 Jan 31;16(5):1078-1091. doi: 10.5114/aoms.2020.92689. eCollection 2020.
9
Challenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: evidence and lessons from Mexico.中低收入国家实现非传染性疾病全民覆盖的挑战与困境:来自墨西哥的证据与经验教训。
Global Health. 2018 Aug 24;14(1):89. doi: 10.1186/s12992-018-0404-3.
《传染:流行病学模型与金融危机》
J Public Health (Oxf). 2014 Mar;36(1):13-7. doi: 10.1093/pubmed/fdt083. Epub 2013 Aug 21.
4
Health disparities from economic burden of diabetes in middle-income countries: evidence from México.中低收入国家糖尿病经济负担导致的健康差距:来自墨西哥的证据。
PLoS One. 2013 Jul 12;8(7):e68443. doi: 10.1371/journal.pone.0068443. Print 2013.
5
Economic costs of diabetes in the U.S. in 2012.2012 年美国糖尿病的经济成本。
Diabetes Care. 2013 Apr;36(4):1033-46. doi: 10.2337/dc12-2625. Epub 2013 Mar 6.
6
[Risk factors and complications in patients with hypertension/diabetes in a regional health district of northeast Brazil].[巴西东北部某地区卫生区高血压/糖尿病患者的危险因素及并发症]
Rev Esc Enferm USP. 2012 Oct;46(5):1125-32. doi: 10.1590/s0080-62342012000500013.
7
Epidemiology in Latin America and the Caribbean: current situation and challenges.拉丁美洲和加勒比地区的流行病学:现状与挑战。
Int J Epidemiol. 2012 Apr;41(2):557-71. doi: 10.1093/ije/dys017. Epub 2012 Mar 9.
8
Confronting the chronic disease burden in Latin America and the Caribbean.应对拉丁美洲和加勒比地区的慢性病负担。
Health Aff (Millwood). 2010 Dec;29(12):2142-8. doi: 10.1377/hlthaff.2010.1038.
9
Global healthcare expenditure on diabetes for 2010 and 2030.2010 年和 2030 年全球糖尿病医疗支出。
Diabetes Res Clin Pract. 2010 Mar;87(3):293-301. doi: 10.1016/j.diabres.2010.01.026. Epub 2010 Feb 19.
10
The cost of diabetes in Latin America and the Caribbean.拉丁美洲和加勒比地区糖尿病的成本。
Bull World Health Organ. 2003;81(1):19-27. Epub 2003 Mar 11.